+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Regeneron Pharmaceuticals Inc - logo

Regeneron is a biotechnology company with its headquarters in New York City. Their product portfolio includes Praluent, Eylea and Arcalyst. Regeneron is a key player in research and development including drug discovery, human antibody technologies and genomics. Regeneron scientists focus on discovering new drug targets and developing effective product candidates through the proprietary VelociSuite platform of genetic technologies. In 2015 Regeneron announced a new collaboration with Sanofi to develop immuno-oncology treatments with a plan to begin clinical trials in 2016.

ANGPTL3 protein inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

ANGPTL3 protein inhibitors - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
From
Diagnostic Specialty Antibodies Global Market Report 2024 - Product Thumbnail Image

Diagnostic Specialty Antibodies Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Head and Neck Cancer Diagnostics Global Market Report 2024 - Product Thumbnail Image

Head and Neck Cancer Diagnostics Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Bispecific antibody - Competitive landscape, 2023 - Product Thumbnail Image

Bispecific antibody - Competitive landscape, 2023

  • Report
  • May 2023
  • 450 Pages
  • Global
From
From
Chronic Rhinosinusitis - Pipeline Insight, 2024 - Product Thumbnail Image

Chronic Rhinosinusitis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
Nerve growth factor inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

Nerve growth factor inhibitors - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
From
From
IL-6 Receptor Antagonist - Pipeline Insight, 2024 - Product Thumbnail Image

IL-6 Receptor Antagonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Cancer Therapeutics Market Report and Forecast 2023-2031 - Product Thumbnail Image

Cancer Therapeutics Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
From
Oropharyngeal Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Oropharyngeal Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 50 Pages
  • Global
From
From
From
Loading Indicator